ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,00%
Bitcoin
67.675,19
-0,07%
Brent Oil
81,295
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Cerus Corp (CERS)

  7. Cerus Corp (CERS) Notícias

CERS

Cerus (CERS)

Cerus Corp
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CERS
DataHoraFonteTítuloCódigoCompanhia
31/05/202417:01Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:CERSCerus Corp
22/05/202409:30Business WireCerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor ConferenceNASDAQ:CERSCerus Corp
14/05/202419:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERSCerus Corp
02/05/202417:00Business WireCerus Corporation Announces First Quarter 2024 Financial ResultsNASDAQ:CERSCerus Corp
18/04/202409:30Business WireCerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024NASDAQ:CERSCerus Corp
26/03/202409:30Business WireCerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf LifeNASDAQ:CERSCerus Corp
19/03/202409:00Business WireCerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery PatientsNASDAQ:CERSCerus Corp
08/03/202418:46Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CERSCerus Corp
05/03/202418:58Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CERSCerus Corp
05/03/202418:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CERSCerus Corp
05/03/202418:00Business WireCerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:CERSCerus Corp
20/02/202410:30Business WireCerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024NASDAQ:CERSCerus Corp
14/02/202418:21Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CERSCerus Corp
01/02/202410:30Business WireCerus Corporation to Participate in Upcoming Investor ConferencesNASDAQ:CERSCerus Corp
08/01/202410:30Business WireCerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business UpdateNASDAQ:CERSCerus Corp
16/11/202302:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CERSCerus Corp
02/11/202318:28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CERSCerus Corp
02/11/202318:25Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CERSCerus Corp
02/11/202317:53Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CERSCerus Corp
02/11/202317:00Business WireCerus Corporation Announces Third Quarter 2023 Financial ResultsNASDAQ:CERSCerus Corp
19/10/202309:30Business WireCerus Corporation to Release Third Quarter 2023 Financial Results on November 2, 2023NASDAQ:CERSCerus Corp
10/10/202309:30Business WireCerus Corporation Announces Workshop and Abstracts at the 2023 AABB Annual MeetingNASDAQ:CERSCerus Corp
27/09/202309:30Business WireCerus Corporation Announces the Appointment of Alicia Goodman as New Chief Human Resources OfficerNASDAQ:CERSCerus Corp
12/09/202309:30Business WireCerus Corporation to Participate in the 2023 Cantor Global Healthcare ConferenceNASDAQ:CERSCerus Corp
02/08/202317:00Business WireCerus Corporation Announces Second Quarter 2023 Financial ResultsNASDAQ:CERSCerus Corp
19/07/202309:30Business WireCerus Corporation to Release Second Quarter 2023 Financial Results on August 2, 2023NASDAQ:CERSCerus Corp
15/06/202309:30Business WireCerus Corporation Announces Symposium and Abstracts at the 33rd Regional ISBT CongressNASDAQ:CERSCerus Corp
14/06/202309:30Business WireCerus Corporation Celebrates World Blood Donor Day 2023NASDAQ:CERSCerus Corp
12/06/202310:39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CERSCerus Corp
09/06/202317:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CERSCerus Corp
 Apresentando as notícias mais relevantes sobre:NASDAQ:CERS

Seu Histórico Recente

ASX
TNV
TSXV
MVM
Millenmin Ventures
BIT
P19K43
BNP Paribas Issuance
BIT
IGV
I Grandi Viaggi
BIT
P1CSX1
BNP Paribas Issuance
BIT
YRM
Rosetti Marino
LSE
BR33
Citi Fun 25
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados